1
关注
475
浏览

公司应如何设计和控制他们的纸质文件系统,以防止未经授权的GMP数据的重新出现?

查看全部 1 个回答

trer234 二阶会员 用户来自于: 广东省深圳市
2023-10-26 22:44

 The template (blank) forms used for manual recordings may be created in an electronic system (Word, Excel, etc.). The corresponding master documents should be approved and controlled electronically or in paper versions. The following expectations should be considered for the template (blank) form:

用于手工记录的模板(空白)表格可以在电子系统(Word、Excel等)中创建。相应的主文件应以电子方式或纸质方式批准和控制。对模板(空白)表格应考虑以下期望。

· have a unique reference number (including version number) and include reference to corresponding SOP number

有一个独特的参考编号(包括版本号),并包括对相应SOP编号的参考

· should be stored in a manner which ensures appropriate version control

应以确保适当版本控制的方式进行存储

· if signed electronically, should use a secure e-signature

如果以电子方式签署,应使用安全的电子签章

The distribution of template records (e.g. 'blank' forms) should be controlled. The following expectations should be considered where appropriate, based on data risk and criticality:

应控制模板记录(如 "空白 "表格)的分发。应根据数据风险和关键性,酌情考虑以下预期。

· enable traceability for issuance of the blank form by using a bound logbook with numbered pages or other appropriate system. For loose leaf template forms, the distribution date, a sequential issuing number, the number of the copies distributed, the department name where the blank forms are distributed, etc. should be known

通过使用带有页码的装订记录本或其他适当的系统,使空白表格的发放具有可追溯性。对于活页模板表格,应该知道分发日期、连续的签发号码、分发的份数、分发空白表格的部门名称等。

· Distributed copies should be designed to avoid photocoping either by using a secure stamp, or by the use of paper colour code not available in the working areas or another appropriate system.

分发的副本应通过使用安全印章,或使用工作区域内没有的纸张颜色代码或其他适当的系统来避免拍照。


关于作者

问题动态

发布时间
2023-10-26 22:43
更新时间
2023-10-26 22:44
关注人数
1 人关注

推荐内容

Is it acceptable to only save the final results from reprocessed laboratory chromatography?
Is FDA allowed to look at electronic records?
How often should audit trails be reviewed?
How should blank forms be controlled?
Should personnel be trained in preventing and detecting data integrity issues
基于风险的电子数据审查是否可以接受?
How should access to CGMP computer systems be restricted?
What is an “audit trail”?
欧盟GMP是否要求实施数据完整性的具体程序?
对与数据完整性有关的自检计划有什么期望?